Did you know that up until now there were no protocols, no true guidelines for doctors in the US in treating AS and SpA? They were simply never created. Thankfully that has just changed. We have been working on this issue for years and now our work is paying off.
“The American College of Rheumatology (ACR) has released new recommendations for the treatment of ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (SpA). The guidelines were developed with the Spondylitis Association of America (SAA) and the Spondyloarthritis Research and Treatment Network.”
The guidelines include “specific, actionable recommendations that clinicians could readily apply in their practices” to better serve the patient.
“The recommendations are divided into five categories:
- Recommendations for the treatment of patients with active AS (pharmacologic and rehabilitation)
- Recommendations for the treatment of patients with stable AS (pharmacologic and rehabilitation)
- Recommendations for the treatment of patients with either active or stable AS
- Recommendations for the treatment of patients with AS and specific impairments or comorbidities (such as advanced hip arthritis, severe kyphosis, acute iritis, and inflammatory bowel disease)
- Education and preventive care recommendations; and
- Recommendations for the treatment of patients with non-radiographic axial SpA.
Each category contains several recommendations pertaining to pharmacologic and non-pharmacologic interventions, followed by supporting evidence and rationale.”
This huge accomplishment wouldn’t have been possible without the generous donations of our members and donors, as SAA provided the foundation moneys for this undertaking, and has been closely involved in the project. This is a big moment for our community and we are thrilled to see this project come to fruition!
The American College of Rheumatology Press Release on the Guidelines can be found here.
Read the Guidelines here.